In a study aimed to characterize the contribution of rare genetic variants to IBD development, Shaw and collaborators found that mutations in complement C2, C3, and CFB were among the top 200 most significant common variants associated with disease in a cohort of 628 pediatric patients (58). This evidence concerns the gene CFB and inflammatory bowel disease.